MYC and cancer: The enhancer overlaps ChIP-seq binding peaks of 8 transcription associated factors in A549 cells, including the enhancer marking p300 co-activator and other TFs such as c-Myc, Max, and SP1 which are linked to cancer development and growth [49-51].